KWR vs MTX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
KWR exhibits a stark divergence between analyst optimism and fundamental health, headlined by a weak Piotroski F-Score of 2/9. While the company shows strong liquidity (Current Ratio 2.42) and impressive year-over-year earnings growth of 48.6%, current profitability is concerning with a negative profit margin (-0.13%) and negative ROE (-0.18%). The stock is currently viewed as a recovery play, supported by a 'Strong Buy' analyst consensus and a target price of $169.20, but the underlying deterministic health scores suggest significant operational instability.
MTX exhibits severe fundamental deterioration, highlighted by a critical Piotroski F-Score of 2/9, indicating weak financial health. While the stock has seen a 39% price increase over the last year, this momentum is decoupled from the underlying data: earnings growth is plummeting (-28.8% YoY) and the dividend payout ratio of 4300% is mathematically unsustainable. Despite a 'Strong Buy' analyst consensus, the combination of negative ROE, stagnant revenue growth, and bearish insider selling suggests a significant valuation risk.
Compare Another Pair
Related Comparisons
KWR vs MTX: Head-to-Head Comparison
This page compares Quaker Chemical Corporation (KWR) and Minerals Technologies Inc. (MTX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.